Patient-Reported Outcomes Evaluating the Impact of Hypo-Fractionated Palliative Quadshot Radiotherapy and Concurrent CDDP Treatment on Health-Related Quality of Life in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

J. Pattanaik(All India Institute of Medical Sciences), S. Mandal(Bose Institute), Raja Pramanik(Cancer Institute (WIA)), V. Ghosh(All India Institute of Medical Sciences), S.K. Samala(All India Institute of Medical Sciences), D.V.S. Praveen(All India Institute of Medical Sciences), Somali Sanyal(Karolinska Institutet), Anubhuti Sharma(All India Institute of Medical Sciences), Ahitagni Biswas(DR. B.R.A. Institute Rotary Cancer Hospital), Suman Bhasker, Swaroop Kumar Pandey(All India Institute of Medical Sciences), Rajeev Kumar(Nalanda Medical College and Hospital), R A.V., M.S. Tanwar(All India Institute of Medical Sciences)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
10.1016/j.ijrobp.2023.06.461
Cited by 0

Related Papers

HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis
|Radiotherapy and Oncology|2022|42
Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysis
|Practical Radiation Oncology|2018|32
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
|Trials|2020|29
Non‐immunological biomarkers for assessment of villous abnormalities in patients with celiac disease
|Journal of Gastroenterology and Hepatology|2019|28
Unusual Uptake of Prostate Specific Tracer 68Ga-PSMA–HBED-CC in a Benign Thyroid Nodule
|Nuclear Medicine and Molecular Imaging|2016|23